Provided by Tiger Trade Technology Pte. Ltd.

Adial Pharmaceuticals

5.24
+0.24004.80%
Volume:29.67K
Turnover:152.24K
Market Cap:13.76M
PE:-0.30
High:5.30
Open:5.01
Low:5.00
Close:5.00
52wk High:10.75
52wk Low:1.31
Shares:2.63M
Float Shares:2.13M
Volume Ratio:0.59
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.7100
EPS(LYR):-11.9306
ROE:-2011.64%
ROA:-40.02%
PB:-0.36
PE(LYR):-0.44

Loading ...

Press Release: Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

Dow Jones
·
Jun 16

Adial Pharmaceuticals director Wendy B. Young files initial beneficial ownership statement

Reuters
·
Jun 16

Adial Pharmaceuticals Initiated at Buy by LUCID CAPITAL MARKETS

Dow Jones
·
Jun 16

Adial Pharmaceuticals initiated with a Buy at Lucid Capital

TIPRANKS
·
Jun 15

Sector Update: Healthcare

MT Newswires Live
·
Jun 12

Top Midday Gainers

MT Newswires Live
·
Jun 12

Adial Pharmaceuticals Completes Azora Merger, Shifts Strategic Focus

TIPRANKS
·
Jun 12

Adial Pharmaceuticals announces acquisition of Azora Therapeutics

TIPRANKS
·
Jun 11

Adial Pharmaceuticals adds Wendy Young to board of directors

Reuters
·
Jun 11

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:44 AM

Reuters
·
Jun 11

Adial Pharmaceuticals acquires Azora Therapeutics, lines up up to $64 million private placement

Reuters
·
Jun 11

Adial Pharmaceuticals - Enters Agreement for up to $64 Mln Private Placement

THOMSON REUTERS
·
Jun 11

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing

THOMSON REUTERS
·
Jun 11

Adial Pharmaceuticals - Post-Deal: Adial Holders 7.7%, Azora Holders 51%, Investors 41.3% of Common Stock

THOMSON REUTERS
·
Jun 11

Adial Pharmaceuticals - Receives $32 Mln Upfront Financing for Pre-Funded Warrants at $2.75 Each

THOMSON REUTERS
·
Jun 11

Adial Pharmaceuticals: Buy Rating Reiterated as AD04’s Precision AUD Strategy Advances; $8 Price Target Maintained

TIPRANKS
·
May 14

Adial Pharmaceuticals Q1 net loss narrows on lower R&D spending

Reuters
·
May 11

Press Release: Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update

Dow Jones
·
May 11

Adial Pharma’s Strategic Options: High-Stakes Search for a Deal Puts Share Price and Long-Term Prospects at Risk

TIPRANKS
·
May 10

Adial Pharmaceuticals Inc expected to post a loss of $1.21 a share - Earnings Preview

Reuters
·
May 09